Pharmaceutical companies in the United States by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Dianthus Therapeutics leads the 34 pharmaceutical companies in the United States ranked by P/S ratio, at 2385, ahead of Protagonist Therapeutics (177) and Cytokinetics (81.6). Figures as of 19 Nov 2026, 19:24 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
34
First
Dianthus Therapeutics2385
Median
7.9
Combined market value
$3.74T
Countries
1
Not ranked
10no P/S ratio on file

Market values as of .

United States
All sectors
Pharmaceuticals
USD
Clear filters
Pharmaceutical companies in the United States by P/S ratio
#CompanyP/S ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Dianthus TherapeuticsDNTH · Health Care2385$4.9B$86.23 2.68% up 108% up United States
2Protagonist TherapeuticsPTGX · Health Care177$8.1B$124.80 1.86% down 51% up United States
3CytokineticsCYTK · Health Care81.6$7.2B$51.56 0.47% up 19% down United States
4InsmedINSM · Health Care52.1$31.6B$144.09 20.28% up 40% down United States
5Rhythm PharmaceuticalsRYTM · Health Care42.7$8.1B$117.00 1.72% down 18% up United States
6BridgeBio PharmaBBIO · Health Care30.4$15.3B$78.31 0.38% up 21% up United States
7Ligand PharmaceuticalsLGND · Health Care21.6$5.8B$289.29 3.15% down 50% up United States
8Eli LillyLLY · Health Care18.5$1.21T$1,355.23 1.99% down 33% up United States
9Royalty PharmaRPRX · Health Care16.4$39.1B$67.97 1.02% down 79% up United States
10TG TherapeuticsTGTX · Health Care16.0$9.8B$65.07 1.60% down 117% up United States
11Mirum PharmaceuticalsMIRM · Health Care12.0$6.3B$95.94 3.73% up 34% up United States
12Axsome TherapeuticsAXSM · Health Care11.1$7.1B$134.77 0.58% up 6% down United States
13Vertex PharmaceuticalsVRTX · Health Care11.0$132.2B$521.52 2.78% down 27% up United States
14Madrigal PharmaceuticalsMDGL · Health Care9.6$9.2B$398.04 0.01% down 27% down United States
15Travere TherapeuticsTVTX · Health Care9.5$4.7B$48.73 3.01% down 45% up United States
16Corcept TherapeuticsCORT · Health Care9.4$7.1B$65.21 3.81% down 10% down United States
17AbbVieABBV · Health Care8.2$500.9B$283.37 0.92% down 25% up United States
18United TherapeuticsUTHR · Health Care7.5$24B$563.76 2.35% down 22% up United States
19Arrowhead PharmaceuticalsARWR · Health Care7.4$6.2B$43.51 0.92% up 13% up United States
20Johnson & JohnsonJNJ · Health Care6.8$641.8B$266.60 2.24% down 34% up United States
21Regeneron PharmaceuticalsREGN · Health Care6.7$96.3B$931.26 1.51% down 28% up United States
22Alnylam PharmaceuticalsALNY · Health Care5.4$20B$149.38 0.01% down 66% down United States
23Merck & CoMRK · Health Care5.0$326.9B$132.60 3.76% down 45% up United States
24Ionis PharmaceuticalsIONS · Health Care4.7$4.5B$26.85 1.97% down 63% down United States
25Abbott LaboratoriesABT · Health Care4.1$180B$103.92 0.54% down 16% down United States
26BioMarin PharmaceuticalBMRN · Health Care3.7$12B$62.07 1.04% up 17% up United States
27ZoetisZTS · Health Care3.5$33.4B$82.23 3.91% down 26% down United States
28Legend BiotechLEGN · Health Care3.0$3.1B$15.99 1.60% down 41% down United States
29PTC TherapeuticsPTCT · Health Care2.9$4.9B$59.14 1.81% down 21% down United States
30Elanco Animal HealthELAN · Health Care2.8$13.3B$26.62 0.32% down 26% up United States
31PfizerPFE · Health Care2.5$157.6B$27.66 1.44% down 15% up United States
32Bristol-Myers SquibbBMY · Health Care2.5$119.7B$58.55 1.70% down 30% up United States
33Amneal PharmaceuticalsAMRX · Health Care2.5$7.4B$21.31 2.61% down 90% up United States
34ViatrisVTRS · Health Care1.6$22.9B$19.98 1.48% down 99% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. 10 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which pharmaceutical companies in the United States rank first by P/S ratio?

Dianthus Therapeutics (2385), Protagonist Therapeutics (177) and Cytokinetics (81.6) are the top three of the 34 pharmaceutical companies in the United States ranked by P/S ratio as of 19 Nov 2026, 19:24 UTC.

How many pharmaceutical companies in the United States are in this ranking?

34 are ranked by P/S ratio. 10 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these pharmaceutical companies in the United States worth together?

The 34 pharmaceutical companies in the United States ranked by P/S ratio have a combined market value of $3.74T as of 19 Nov 2026, 19:24 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Pharmaceutical companies in the United States by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.